HCM Treatment Advances: Why Patient Outcomes Lag Behind

by

The promise of disease modification in hypertrophic cardiomyopathy (HCM) has hit a snag. The highly anticipated ODYSSEY-HCM trial, evaluating mavacamten in patients…

Source link

Related posts:

  1. Why is cold water necessary for bathing in winter?
  2. Study could help predict treatment response for KRASG12C-mutant non-small cell lung cancer
  3. Deep-learning plus MRI helps predict HCC recurrence
  4. Every passenger and transport coming to Pakistan will undergo special inspection

Leave a Comment